157 related articles for article (PubMed ID: 20198623)
1. NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.
Mailloux AW; Clark AM; Young MR
Int J Cancer; 2010 Dec; 127(11):2598-611. PubMed ID: 20198623
[TBL] [Abstract][Full Text] [Related]
2. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
Mailloux AW; Young MR
J Immunol; 2009 Mar; 182(5):2753-65. PubMed ID: 19234170
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S
Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
Lundqvist A; Yokoyama H; Smith A; Berg M; Childs R
Blood; 2009 Jun; 113(24):6120-7. PubMed ID: 19202127
[TBL] [Abstract][Full Text] [Related]
5. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
[TBL] [Abstract][Full Text] [Related]
6. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment.
Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F
J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314
[TBL] [Abstract][Full Text] [Related]
7. Decreased IL-17RB expression impairs CD11b
Teng YS; Liu YG; Chen XH; Wang TT; Cheng P; Lv YP; Kong H; Mao FY; Hao CJ; Yang SM; Chen W; Zhang JY; Peng LS; Han B; Ma Q; Han J; Zou QM; Zhuang Y
Cell Death Dis; 2019 Jan; 10(2):79. PubMed ID: 30692510
[TBL] [Abstract][Full Text] [Related]
8. Tumors induce the formation of suppressor endothelial cells in vivo.
Mulligan JK; Young MR
Cancer Immunol Immunother; 2010 Feb; 59(2):267-77. PubMed ID: 19669642
[TBL] [Abstract][Full Text] [Related]
9. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
[TBL] [Abstract][Full Text] [Related]
10. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
11. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.
Liao C; Xiao W; Zhu N; Liu Z; Yang J; Wang Y; Hong M
Int J Clin Exp Pathol; 2015; 8(3):2535-44. PubMed ID: 26045759
[TBL] [Abstract][Full Text] [Related]
13. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
Yin X; Yan X; Yang Q; Cao H; Liang H
Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
[TBL] [Abstract][Full Text] [Related]
14. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
15. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
[TBL] [Abstract][Full Text] [Related]
16. The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8
Puca E; Probst P; Stringhini M; Murer P; Pellegrini G; Cazzamalli S; Hutmacher C; Gouyou B; Wulhfard S; Matasci M; Villa A; Neri D
Int J Cancer; 2020 May; 146(9):2518-2530. PubMed ID: 31374124
[TBL] [Abstract][Full Text] [Related]
17. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
[TBL] [Abstract][Full Text] [Related]
18. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
[TBL] [Abstract][Full Text] [Related]
19. The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.
Salem ML; El-Naggar SA; Mobasher MA; Elgharabawy RM
J Immunol Res; 2020; 2020():2489407. PubMed ID: 32211442
[TBL] [Abstract][Full Text] [Related]
20. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]